The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase
Open accessAbstract
The increasing incidence of resistance to current HIV-1 therapy underscores the need to develop antiretroviral agents with new mechanisms of action. Integrase, one of three viral enzymes essential for HIV-1 replication, presents an important yet unexploited opportunity for drug development. We describe here the identification and characterization of L-870,810, a small-molecule inhibitor of HIV-1 integrase with potent antiviral activity in cell culture and good pharmacokinetic properties. L-870,810 is an inhibitor with an 8-hydroxy-(1,6)-naphthyridine-7-carboxamide pharmacophore. The compound inhibits HIV-1 integrase-mediated strand transfer, and its antiviral activity in vitro is a direct consequence of this ascribed effect on integration. L-870,810 is mechanistically identical to previously described inhibitors from the diketo acid series; however, viruses selected for resistance to L-870,810 contain mutations (integrase residues 72, 121, and 125) that uniquely confer resistance to the naphthyridine. Conversely, mutations associated with resistance to the diketo acid do not engender naphthyridine resistance. Importantly, the mutations associated with resistance to each of these inhibitors map to distinct regions within the integrase active site. Therefore, we propose a model of the two inhibitors that is consistent with this observation and suggests specific interactions with discrete binding sites for each ligand. These studies provide a structural basis and rationale for developing integrase inhibitors with the potential for unique and nonoverlapping resistance profiles.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94
Halgren, T. A. (1996) · Journal of Computational Chemistry · doi:10.1002/(sici)1096-987x(199604)17:5/6<490::aid-jcc1>3.0.co;2-p · Cited by 5,306
Antiretroviral-Drug Resistance among Patients Recently Infected with HIV
Little, S. J., Holte, S., Routy, J.-P., Daar, E. S., Markowitz, M., Collier, A. C., Koup, R. A., Mellors, J. W., Connick, E., Conway, B., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013552 · Cited by 1,140
Inhibitors of Strand Transfer That Prevent Integration and Inhibit HIV-1 Replication in Cells
Hazuda, D. J., Felock, P., Witmer, M., Wolfe, A., Stillmock, K., Grobler, J. A., Espeseth, A., Gabryelski, L., Schleif, W., Blau, C., et al. (2000) · Science · doi:10.1126/science.287.5453.646 · Cited by 1,131
Self-citationHalgren, T. A. (1996) · Journal of Computational Chemistry · doi:10.1002/(sici)1096-987x(199604)17:5/6<520::aid-jcc2>3.0.co;2-w · Cited by 1,130
Merck molecular force field. IV. conformational energies and geometries for MMFF94
Halgren, T. A., & Nachbar, R. B. (1996) · Journal of Computational Chemistry · doi:10.1002/(sici)1096-987x(199604)17:5/6<587::aid-jcc4>3.0.co;2-q · Cited by 879
Merck molecular force field. III. Molecular geometries and vibrational frequencies for MMFF94
Halgren, T. A. (1996) · Journal of Computational Chemistry · doi:10.1002/(sici)1096-987x(199604)17:5/6<553::aid-jcc3>3.0.co;2-t · Cited by 814
Halgren, T. A. (1996) · Journal of Computational Chemistry · doi:10.1002/(sici)1096-987x(199604)17:5/6<616::aid-jcc5>3.0.co;2-x · Cited by 772
Distance geometry and molecular conformation
(1989) · Choice Reviews Online · doi:10.5860/choice.27-0916 · Cited by 724
A quantitative assay for HIV DNA integration in vivo
Butler, S. L., Hansen, M. S. T., & Bushman, F. D. (2001) · Nature Medicine · doi:10.1038/87979 · Cited by 687
L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitor.
Vacca, J. P., Dorsey, B. D., Schleif, W. A., Levin, R. B., McDaniel, S. L., Darke, P. L., Zugay, J., Quintero, J. C., Blahy, O. M., & Roth, E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.4096 · Cited by 527
Self-citationGoldgur, Y., Craigie, R., Cohen, G. H., Fujiwara, T., Yoshinaga, T., Fujishita, T., Sugimoto, H., Endo, T., Murai, H., & Davies, D. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13040 · Cited by 496
Richman, D. D. (2001) · Nature · doi:10.1038/35073673 · Cited by 419
Chen, J. C.-H., Krucinski, J., Miercke, L. J. W., Finer-Moore, J. S., Tang, A. H., Leavitt, A. D., & Stroud, R. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150220297 · Cited by 404
Grobler, J. A., Stillmock, K., Hu, B., Witmer, M., Felock, P., Espeseth, A. S., Wolfe, A., Egbertson, M., Bourgeois, M., Melamed, J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092056199 · Cited by 399
Self-citationDiscovery of a Novel Binding Trench in HIV Integrase
Schames, J. R., Henchman, R. H., Siegel, J. S., Sotriffer, C. A., Ni, H., & McCammon, J. A. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0341913 · Cited by 354
Espeseth, A. S., Felock, P., Wolfe, A., Witmer, M., Grobler, J., Anthony, N., Egbertson, M., Melamed, J. Y., Young, S., Hamill, T., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200139397 · Cited by 317
Self-citationMaignan, S., Guilloteau, J.-P., Zhou-Liu, Q., Clément-Mella, C., & Mikol, V. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2002 · Cited by 277
Zhuang, L., Wai, J. S., Embrey, M. W., Fisher, T. E., Egbertson, M. S., Payne, L. S., Guare, Vacca, J. P., Hazuda, D. J., Felock, P. J., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm025553u · Cited by 270
Self-citationHIV Integrase Structure and Function
Esposito, D., & Craigie, R. (1999) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60304-8 · Cited by 227
Sampling and efficiency of metric matrix distance geometry: A novel partial metrization algorithm
Kuszewski, J., Nilges, M., & Brünger, A. T. (1992) · Journal of Biomolecular NMR · doi:10.1007/bf02192799 · Cited by 203
HIV-1 Integrase: Structural Organization, Conformational Changes, and Catalysis
Asante-Appiah, E., & Skalka, A. M. (1999) · Advances in Virus Research · doi:10.1016/s0065-3527(08)60306-1 · Cited by 192
4-Aryl-2,4-dioxobutanoic Acid Inhibitors of HIV-1 Integrase and Viral Replication in Cells
Wai, J. S., Egbertson, M. S., Payne, L. S., Fisher, T. E., Embrey, M. W., Tran, L. O., Melamed, J. Y., Langford, H. M., Guare, Zhuang, L., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000176b · Cited by 188
Self-citationShaw-Reid, C. A., Munshi, V., Graham, P., Wolfe, A. L., Witmer, M. V., Danzeisen, R. C., Olsen, D. B., Carroll, S. S., Embrey, M. W., Wai, J. S. M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200621200 · Cited by 159
Self-citationSaag, M. S., Emini, E. A., Laskin, O. L., Douglas, J. A., Lapidus, W. I., Schleif, W. A., Whitley, R. J., HILDEBRAND, C. S., Byrnes, V. W., Kappes, J. C., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310073291502 · Cited by 156
Self-citationSumma, V., Petrocchi, A., Pace, P., Matassa, V. G., Francesco, R. D., Altamura, S., Tomei, L., Koch, U., & Neuner, P. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0342109 · Cited by 124
Self-citationFikkert, V., Maele, B. V., Vercammen, J., Hantson, A., Remoortel, B. V., Michiels, M., Gurnari, C., Pannecouque, C. C., Maeyer, M. D., Engelborghs, Y., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.21.11459-11470.2003 · Cited by 104
Hazuda, D. J., Felock, P. J., Hastings, J. C., Pramanik, B., & Wolfe, A. L. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.7005-7011.1997 · Cited by 102
Self-citationPatented small molecule inhibitors of HIV-1 integrase: a 10-year saga
Neamati, N. (2002) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.12.5.709 · Cited by 80
Inhibition of Human Immunodeficiency Virus Type 1 Integration by Diketo Derivatives
Pluymers, W., Pais, G. C. G., Maele, B. V., Pannecouque, C. C., Fikkert, V., Burke, T. R., Clercq, E. D., Witvrouw, M., Neamati, N., & Debyser, Z. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.10.3292-3297.2002 · Cited by 47
Cited by
Molecular Dynamics Simulation for All
Hollingsworth, S. A., & Dror, R. O. (2018) · Neuron · doi:10.1016/j.neuron.2018.08.011 · Cited by 3,257
Molecular dynamics simulations and drug discovery
Durrant, J. D., & McCammon, J. A. (2011) · BMC Biology · doi:10.1186/1741-7007-9-71 · Cited by 1,403
Molecular Dynamics: Survey of Methods for Simulating the Activity of Proteins
Adcock, S. A., & McCammon, J. A. (2006) · Chemical Reviews · doi:10.1021/cr040426m · Cited by 1,272
HIV-1 Antiretroviral Drug Therapy
Arts, E. J., & Hazuda, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007161 · Cited by 851
Self-citationIntegrase inhibitors to treat HIV/Aids
Pommier, Y., Johnson, A. A., & Marchand, C. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1660 · Cited by 688
Metadata
- Authors
- Hazuda, D. J., Anthony, N. J., Gomez, R. P., Jolly, S. M., Wai, J. S., Zhuang, L., Fisher, T. E., Embrey, M., Guare, J. P., Egbertson, M. S., Vacca, J. P., Huff, J. R., Felock, P. J., Witmer, M. V., Stillmock, K. A., Danovich, R., Grobler, J., Miller, M. D., Espeseth, A. S., Jin, L., Chen, I.-W., Lin, J. H., Kassahun, K., Ellis, J. D., Wong, B. K., Xu, W., Pearson, P. G., Schleif, W. A., Cortese, R., Emini, E., Summa, V., Holloway, M. K., & Young, S. D.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2004-07-26
- Volume
- 101
- Issue
- 31
- Pages
- 11233-11238
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2151389386
- Cited by
- 333
- References
- 29
- FWCI
- 16.94
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.